2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
doi 10.14748/ssm.v47i2.1223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical University Prof. Dr. Paraskev Stoyanov - Varna

Related search

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer

Scientific Reports
Multidisciplinary
2019English

Occult Tumor Cell Contamination in Patients With Stage II/III Breast Cancer Receiving Sequential High-Dose Chemotherapy

Bone Marrow Transplantation
TransplantationHematology
2003English

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

PLoS ONE
Multidisciplinary
2016English

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches

Oncologist
Cancer ResearchMedicineOncology
2005English

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

Test of a Weight Gain Prevention Intervention in Stage II and III Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data

Cancer Research and Treatment
Cancer ResearchOncology
2018English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy